Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAOR.L Regulatory News (AOR)

  • There is currently no data for AOR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New Patent Issued

4 Jul 2018 07:00

RNS Number : 5006T
AorTech International PLC
04 July 2018
 

 4 July 2018 

AorTech International plc 

("AorTech" or the "Company") 

  

New Patent Issued

 

AorTech is pleased to announce that the Brazilian Patent Office has recently granted Patent Number PI 0711694-2 entitled Biostable Gels. The invention relates to biostable gels, the processes for their preparation and their use in the manufacture and repair of biomaterials and medical devices or implants, in particular soft tissue implants such as breast implants.

 

Bill Brown, Chairman of AorTech said: "The issue of this patent further expands AorTech's patent portfolio, particularly in the area of breast implants. Brazil is one of the largest markets for breast enhancement outside of the USA and is therefore an important patent territory. The portfolio of IP relating to Breast Implants is not currently licensed by AorTech."

  

For further information contact: 

  

AorTech International plc Tel: +44 (0)7730 718296  

Bill Brown, Chairman  

  

Stockdale Securities Limited Tel: +44 (0)20 7601 6100  

Tom Griffiths/David Coaten  

  

About AorTech: 

  

AorTech has developed biostable, implantable polymers, including Elast-Eon™ and ECSil™ the world's leading long-term implantable co-polymers, now manufactured on their behalf by Biomerics LLC in Utah, USA. With several million implants and seven years of successful clinical use, AorTech polymers are being developed and used in cardiology and urological applications, including pacing leads, cardiac cannulae, stents and neuro stimulation devices. Devices manufactured from AorTech polymers have numerous US FDA PMA approvals, 510ks, CE Marks, Australian TGA and Japanese Ministry of Health approvals. 

  

Elast-Eon™ and ECSil™'s biostability is comparable to silicone while exhibiting excellent mechanical, blood contacting and flex-fatigue properties. These polymers can be processed using conventional thermoplastic extrusion and moulding techniques. A range of materials in a variety of application-specific formulations for use in medical devices and components are available.

 

In addition to the licensing of biostable polymers, AorTech is now developing medical devices utilizing the key properties of its world class polymers.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDLLFERDVIVIIT
Date   Source Headline
12th Dec 20178:58 amRNSHolding(s) in Company
12th Dec 20178:30 amRNSHolding(s) in Company
11th Dec 20179:08 amRNSInterim Results
11th Dec 20177:51 amRNSSettlement of Litigation
8th Dec 20174:08 pmRNSCORRECTION: Holdings in Company
20th Nov 20177:01 amRNSResponse to Media Comment
20th Nov 20177:00 amRNSChange of Adviser
29th Sep 20178:17 amRNSResult of AGM
14th Sep 20177:00 amRNSHolding(s) in Company
8th Sep 20173:48 pmRNSHolding(s) in Company
31st Aug 20171:05 pmRNSNotice of AGM and Posting of Accounts
18th Aug 20175:24 pmRNSHolding(s) in Company
18th Aug 20173:10 pmRNSHolding(s) in Company
16th Aug 20177:00 amRNSFinal Results
13th Jul 20174:49 pmRNSHolding(s) in Company
27th Mar 20178:28 amRNSHolding(s) in Company
13th Mar 20177:00 amRNSHolding(s) in Company
18th Jan 20177:00 amRNSHolding(s) in Company
6th Jan 20173:12 pmRNSHolding(s) in Company
21st Dec 20167:00 amRNSInterim Results
14th Oct 20163:41 pmRNSBoard Change
27th Sep 20165:09 pmRNSResult of AGM
21st Sep 20165:28 pmRNSHolding(s) in Company
15th Aug 20167:00 amRNSFinal Results
29th Jul 20162:58 pmRNSChange of Website
10th Jun 20165:46 pmRNSHolding(s) in Company
31st May 20168:39 amRNSHolding(s) in Company
9th May 20169:15 amRNSHolding(s) in Company
22nd Apr 20164:45 pmRNSHolding(s) in Company
29th Dec 201512:55 pmRNSHolding(s) in Company
23rd Dec 20153:52 pmRNSHolding(s) in Company
21st Dec 20152:57 pmRNSResult of General Meeting of Loan Note Holders
2nd Dec 20157:00 amRNSConversion of loan notes update
27th Nov 20157:33 amRNSInterim Results
24th Sep 201512:05 pmRNSResult of AGM and Share Capital Reorganisation
1st Sep 20158:13 amRNSNotice of AGM and Posting of Accounts
10th Aug 20155:37 pmRNSHolding(s) in Company
7th Aug 20157:00 amRNSFinal Results
28th May 20158:40 amRNSBoard Change
15th May 20152:56 pmRNSHolding(s) in Company
16th Apr 20157:00 amRNSUpdate
27th Nov 20147:00 amRNSInterim Results
30th Sep 201411:48 amRNSResult of AGM
18th Aug 20147:00 amRNSPreliminary results for the year to 31 March 2014
16th Jun 20147:00 amRNSTrading and Commercial Update
13th Dec 20139:00 amRNSUnaudited interim results to 30 September 2013
3rd Dec 20137:00 amRNSBoard Reorganisation
4th Nov 20137:00 amRNSHolding(s) in Company
17th Oct 20133:45 pmRNSHolding(s) in Company
11th Oct 20134:17 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.